Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 8.73891130 |
2 | axon ensheathment in central nervous system (GO:0032291) | 8.73891130 |
3 | fatty acid elongation (GO:0030497) | 6.70866515 |
4 | ensheathment of neurons (GO:0007272) | 5.62676597 |
5 | axon ensheathment (GO:0008366) | 5.62676597 |
6 | myelination (GO:0042552) | 5.51958529 |
7 | proteasome assembly (GO:0043248) | 4.89599129 |
8 | myelin maintenance (GO:0043217) | 4.85711139 |
9 | cholesterol biosynthetic process (GO:0006695) | 4.49688141 |
10 | desmosome organization (GO:0002934) | 4.45619512 |
11 | adhesion of symbiont to host cell (GO:0044650) | 4.36449231 |
12 | virion attachment to host cell (GO:0019062) | 4.36449231 |
13 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.32098311 |
14 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.28004747 |
15 | skin morphogenesis (GO:0043589) | 4.24971588 |
16 | keratinization (GO:0031424) | 4.20721211 |
17 | signal peptide processing (GO:0006465) | 4.15949733 |
18 | response to redox state (GO:0051775) | 4.13400652 |
19 | establishment of skin barrier (GO:0061436) | 4.10763164 |
20 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.02724257 |
21 | sterol biosynthetic process (GO:0016126) | 4.01147555 |
22 | amyloid precursor protein metabolic process (GO:0042982) | 3.99136474 |
23 | response to lipoprotein particle (GO:0055094) | 3.97972657 |
24 | regulation of water loss via skin (GO:0033561) | 3.93559020 |
25 | type B pancreatic cell proliferation (GO:0044342) | 3.92746620 |
26 | apical protein localization (GO:0045176) | 3.90556386 |
27 | nucleotide transmembrane transport (GO:1901679) | 3.77379869 |
28 | amyloid precursor protein catabolic process (GO:0042987) | 3.69144992 |
29 | creatine metabolic process (GO:0006600) | 3.65567311 |
30 | eye photoreceptor cell differentiation (GO:0001754) | 3.61497936 |
31 | photoreceptor cell differentiation (GO:0046530) | 3.61497936 |
32 | asymmetric protein localization (GO:0008105) | 3.58555244 |
33 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.57549943 |
34 | oligodendrocyte differentiation (GO:0048709) | 3.54876870 |
35 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.54378366 |
36 | keratinocyte proliferation (GO:0043616) | 3.48533473 |
37 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.48374448 |
38 | negative regulation of neurotransmitter transport (GO:0051589) | 3.47710465 |
39 | glycosylceramide metabolic process (GO:0006677) | 3.46973361 |
40 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.46622893 |
41 | magnesium ion transport (GO:0015693) | 3.43257433 |
42 | adhesion of symbiont to host (GO:0044406) | 3.42269733 |
43 | cell adhesion mediated by integrin (GO:0033627) | 3.40138650 |
44 | membrane raft organization (GO:0031579) | 3.39660361 |
45 | protein deneddylation (GO:0000338) | 3.36871468 |
46 | response to methylmercury (GO:0051597) | 3.35279903 |
47 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.35103266 |
48 | ER overload response (GO:0006983) | 3.34805666 |
49 | substantia nigra development (GO:0021762) | 3.33898663 |
50 | hemidesmosome assembly (GO:0031581) | 3.32962183 |
51 | glycerophospholipid catabolic process (GO:0046475) | 3.32325796 |
52 | import into cell (GO:0098657) | 3.30761844 |
53 | regulation of lipoprotein metabolic process (GO:0050746) | 3.27743609 |
54 | nuclear envelope reassembly (GO:0031468) | 3.27585820 |
55 | mitotic nuclear envelope reassembly (GO:0007084) | 3.27585820 |
56 | protein retention in ER lumen (GO:0006621) | 3.21018310 |
57 | isoprenoid biosynthetic process (GO:0008299) | 3.20010979 |
58 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.19354299 |
59 | wound healing, spreading of epidermal cells (GO:0035313) | 3.15566972 |
60 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.14493678 |
61 | positive regulation of actin filament depolymerization (GO:0030836) | 3.14091626 |
62 | negative regulation of protein localization to cell surface (GO:2000009) | 3.12738915 |
63 | regulation of collateral sprouting (GO:0048670) | 3.10928461 |
64 | protein maturation by protein folding (GO:0022417) | 3.10468024 |
65 | hair cycle (GO:0042633) | 3.08881842 |
66 | molting cycle (GO:0042303) | 3.08881842 |
67 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.08553937 |
68 | cullin deneddylation (GO:0010388) | 3.08061129 |
69 | ribosome assembly (GO:0042255) | 3.07621893 |
70 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.03075371 |
71 | negative regulation of ligase activity (GO:0051352) | 3.03075371 |
72 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.02343810 |
73 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.00681711 |
74 | protein heterotrimerization (GO:0070208) | 2.98317321 |
75 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.96509747 |
76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.95408060 |
77 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.94969756 |
78 | astrocyte development (GO:0014002) | 2.94683037 |
79 | protein palmitoylation (GO:0018345) | 2.94607369 |
80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.93340127 |
81 | L-phenylalanine catabolic process (GO:0006559) | 2.93340127 |
82 | basement membrane organization (GO:0071711) | 2.92285210 |
83 | response to testosterone (GO:0033574) | 2.91725370 |
84 | GPI anchor biosynthetic process (GO:0006506) | 2.86823436 |
85 | protein localization to endosome (GO:0036010) | 2.86789325 |
86 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.86412095 |
87 | endodermal cell differentiation (GO:0035987) | 2.84697763 |
88 | establishment of mitochondrion localization (GO:0051654) | 2.84166518 |
89 | membrane protein ectodomain proteolysis (GO:0006509) | 2.83922547 |
90 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.81832544 |
91 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.81402637 |
92 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.80398572 |
93 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.79644763 |
94 | positive regulation of glial cell differentiation (GO:0045687) | 2.79557125 |
95 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.79460565 |
96 | response to hepatocyte growth factor (GO:0035728) | 2.79460565 |
97 | negative regulation of JUN kinase activity (GO:0043508) | 2.77725218 |
98 | myelination in peripheral nervous system (GO:0022011) | 2.77471991 |
99 | peripheral nervous system axon ensheathment (GO:0032292) | 2.77471991 |
100 | cellular response to vitamin (GO:0071295) | 2.76489035 |
101 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.75543520 |
102 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.74556062 |
103 | very long-chain fatty acid metabolic process (GO:0000038) | 2.73577584 |
104 | copper ion homeostasis (GO:0055070) | 2.72878900 |
105 | acyl-CoA biosynthetic process (GO:0071616) | 2.72771121 |
106 | thioester biosynthetic process (GO:0035384) | 2.72771121 |
107 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71882937 |
108 | natural killer cell mediated immunity (GO:0002228) | 2.71882937 |
109 | collagen fibril organization (GO:0030199) | 2.71424780 |
110 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.71059268 |
111 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.70735784 |
112 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.70456469 |
113 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.70456469 |
114 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.70246635 |
115 | regulation of translational termination (GO:0006449) | 2.68367601 |
116 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.66240533 |
117 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.66240533 |
118 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.66240533 |
119 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.66164784 |
120 | nucleotide transport (GO:0006862) | 2.65636142 |
121 | GPI anchor metabolic process (GO:0006505) | 2.64898042 |
122 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.64213104 |
123 | neutrophil activation involved in immune response (GO:0002283) | 2.63732600 |
124 | peptidyl-cysteine modification (GO:0018198) | 2.63301588 |
125 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.62058530 |
126 | sprouting angiogenesis (GO:0002040) | 2.62024424 |
127 | Golgi transport vesicle coating (GO:0048200) | 2.61435850 |
128 | COPI coating of Golgi vesicle (GO:0048205) | 2.61435850 |
129 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.60674056 |
130 | axon development (GO:0061564) | 2.60335088 |
131 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.59778809 |
132 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.59056924 |
133 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.59056924 |
134 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.57945675 |
135 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.57945675 |
136 | prostanoid biosynthetic process (GO:0046457) | 2.57341854 |
137 | prostaglandin biosynthetic process (GO:0001516) | 2.57341854 |
138 | protein hydroxylation (GO:0018126) | 2.56614001 |
139 | extracellular fibril organization (GO:0043206) | 2.56602577 |
140 | endothelial cell morphogenesis (GO:0001886) | 2.55319925 |
141 | peptide cross-linking (GO:0018149) | 2.51430763 |
142 | keratan sulfate catabolic process (GO:0042340) | 2.51183970 |
143 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.49939117 |
144 | protein heterotetramerization (GO:0051290) | 2.49832361 |
145 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.49599749 |
146 | keratinocyte differentiation (GO:0030216) | 2.49102528 |
147 | L-phenylalanine metabolic process (GO:0006558) | 2.47712785 |
148 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.47712785 |
149 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.47383850 |
150 | cellular copper ion homeostasis (GO:0006878) | 2.45804086 |
151 | ventricular cardiac muscle cell development (GO:0055015) | 2.45697644 |
152 | hyaluronan catabolic process (GO:0030214) | 2.45524402 |
153 | response to lead ion (GO:0010288) | 2.44909245 |
154 | linoleic acid metabolic process (GO:0043651) | 2.44655170 |
155 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.44355100 |
156 | wound healing, spreading of cells (GO:0044319) | 2.43755669 |
157 | tissue regeneration (GO:0042246) | 2.41369709 |
158 | positive regulation of gliogenesis (GO:0014015) | 2.41177536 |
159 | negative regulation of acute inflammatory response (GO:0002674) | 2.40750388 |
160 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.40279938 |
161 | dopamine biosynthetic process (GO:0042416) | 2.40268253 |
162 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.38360026 |
163 | sequestering of metal ion (GO:0051238) | 2.38151401 |
164 | positive regulation of ligase activity (GO:0051351) | 2.38028998 |
165 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.37464407 |
166 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.37280909 |
167 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.36030884 |
168 | fibril organization (GO:0097435) | 2.35565268 |
169 | regulation of osteoblast proliferation (GO:0033688) | 2.35244185 |
170 | peptidyl-proline hydroxylation (GO:0019511) | 2.34555173 |
171 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.34381312 |
172 | response to dietary excess (GO:0002021) | 2.34338245 |
173 | positive regulation of osteoblast proliferation (GO:0033690) | 2.31039106 |
174 | heme transport (GO:0015886) | 2.31033927 |
175 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.30897359 |
176 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.30671837 |
177 | protein neddylation (GO:0045116) | 2.30344023 |
178 | peripheral nervous system development (GO:0007422) | 2.29043038 |
179 | actin filament depolymerization (GO:0030042) | 2.28946607 |
180 | cellular response to vitamin D (GO:0071305) | 2.28598797 |
181 | lipopolysaccharide metabolic process (GO:0008653) | 2.28194740 |
182 | Golgi to plasma membrane protein transport (GO:0043001) | 2.28127296 |
183 | L-amino acid import (GO:0043092) | 2.27330117 |
184 | sphingosine metabolic process (GO:0006670) | 2.26999521 |
185 | tricarboxylic acid cycle (GO:0006099) | 2.26417022 |
186 | cell redox homeostasis (GO:0045454) | 2.21793260 |
187 | regulation of ligase activity (GO:0051340) | 2.21657994 |
188 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.20687855 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.71981674 |
2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.37542658 |
3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.98828153 |
4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.95553327 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.88683801 |
6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.76328356 |
7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.67170664 |
8 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.56035002 |
9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.53988895 |
10 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.50066673 |
11 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.46373509 |
12 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.40303980 |
13 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.40303980 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.32942969 |
15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.32596533 |
16 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22685742 |
17 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.21675379 |
18 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.14365210 |
19 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12593677 |
20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11096736 |
21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.08663539 |
22 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.08108535 |
23 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.08108535 |
24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.05260886 |
25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03133515 |
26 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.98893449 |
27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95985587 |
28 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.94480838 |
29 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.88023164 |
30 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.84150593 |
31 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.82071300 |
32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.77156286 |
33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75438021 |
34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.71953372 |
35 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.70942305 |
36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.69860764 |
37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.68187090 |
38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.67206742 |
39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.66259715 |
40 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.65577421 |
41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.64957858 |
42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64288619 |
43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.61870287 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58677116 |
45 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.56458852 |
46 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.55964791 |
47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.54298764 |
48 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.54257741 |
49 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.54026097 |
50 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.53679808 |
51 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53489535 |
52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52159842 |
53 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.51535410 |
54 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.50899887 |
55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.50460163 |
56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50297714 |
57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49938871 |
58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49423218 |
59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48391433 |
60 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47170293 |
61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.46693267 |
62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40644236 |
63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37907405 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36685997 |
65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.35202754 |
66 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31714617 |
67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30903356 |
68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29895943 |
69 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29843908 |
70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29389152 |
71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28842431 |
72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28739670 |
73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27732023 |
74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27480547 |
75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27055145 |
76 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26530233 |
77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25301007 |
78 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.24960585 |
79 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.24261905 |
80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23732572 |
81 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22942871 |
82 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19748298 |
83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19224993 |
84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18713324 |
85 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17599347 |
86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17560478 |
87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15950022 |
88 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15587783 |
89 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15539620 |
90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14277132 |
91 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13807604 |
92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13734755 |
93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13715348 |
94 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13527512 |
95 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.13279473 |
96 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13044991 |
97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11966997 |
98 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11820423 |
99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11594621 |
100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10646896 |
101 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10427774 |
102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10187021 |
103 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09265876 |
104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08235409 |
105 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08171837 |
106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07936067 |
107 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07511702 |
108 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06238641 |
109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06222036 |
110 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05340454 |
111 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05254586 |
112 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.05251822 |
113 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04929622 |
114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04630120 |
115 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.04253898 |
116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03663196 |
117 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03296565 |
118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03038268 |
119 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.02483463 |
120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02311369 |
121 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01690469 |
122 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.01658603 |
123 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01610077 |
124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01495977 |
125 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01218618 |
126 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01056996 |
127 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00990011 |
128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00026410 |
129 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99679942 |
130 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99679942 |
131 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99589886 |
132 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99475377 |
133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99300225 |
134 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99079933 |
135 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98255575 |
136 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98079052 |
137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97444269 |
138 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97361268 |
139 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97154316 |
140 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96901976 |
141 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96767206 |
142 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95925409 |
143 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95647292 |
144 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.95192351 |
145 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.95192351 |
146 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.95192351 |
147 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94894879 |
148 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94618906 |
149 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94280106 |
150 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94069054 |
151 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92385964 |
152 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92378618 |
153 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92297035 |
154 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91950826 |
155 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91804468 |
156 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.90498362 |
157 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.87215787 |
158 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86260005 |
159 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86143790 |
160 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85566175 |
161 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83951117 |
162 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83578544 |
163 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.83330408 |
164 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79717750 |
165 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.79438180 |
166 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.79115351 |
167 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78704970 |
168 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.78367625 |
169 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.78367625 |
170 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78328164 |
171 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.78214556 |
172 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.78036899 |
173 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77173105 |
174 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77151908 |
175 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.77099842 |
176 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.76948884 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000920_abnormal_myelination | 5.10297783 |
2 | MP0008438_abnormal_cutaneous_collagen | 4.14173428 |
3 | MP0003950_abnormal_plasma_membrane | 3.83277595 |
4 | MP0002796_impaired_skin_barrier | 3.55472012 |
5 | MP0003705_abnormal_hypodermis_morpholog | 3.05399414 |
6 | MP0005058_abnormal_lysosome_morphology | 3.00465174 |
7 | MP0003690_abnormal_glial_cell | 3.00426192 |
8 | MP0003195_calcinosis | 2.91894444 |
9 | MP0003329_amyloid_beta_deposits | 2.79696520 |
10 | MP0006054_spinal_hemorrhage | 2.79580872 |
11 | MP0003566_abnormal_cell_adhesion | 2.76111650 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.65360591 |
13 | MP0004043_abnormal_pH_regulation | 2.60892393 |
14 | MP0002060_abnormal_skin_morphology | 2.47889450 |
15 | MP0005501_abnormal_skin_physiology | 2.40808573 |
16 | MP0003634_abnormal_glial_cell | 2.31392713 |
17 | MP0002295_abnormal_pulmonary_circulatio | 2.31035904 |
18 | MP0004272_abnormal_basement_membrane | 2.23789632 |
19 | MP0004270_analgesia | 2.16459556 |
20 | MP0005171_absent_coat_pigmentation | 2.10541282 |
21 | MP0003941_abnormal_skin_development | 2.06538980 |
22 | MP0000013_abnormal_adipose_tissue | 2.01676159 |
23 | MP0005451_abnormal_body_composition | 1.91756295 |
24 | MP0002877_abnormal_melanocyte_morpholog | 1.87376509 |
25 | MP0000604_amyloidosis | 1.84688559 |
26 | MP0003191_abnormal_cellular_cholesterol | 1.82548046 |
27 | MP0001299_abnormal_eye_distance/ | 1.74495701 |
28 | MP0001216_abnormal_epidermal_layer | 1.73943624 |
29 | MP0005408_hypopigmentation | 1.66043346 |
30 | MP0004947_skin_inflammation | 1.64263602 |
31 | MP0003136_yellow_coat_color | 1.61089031 |
32 | MP0010234_abnormal_vibrissa_follicle | 1.59592934 |
33 | MP0001905_abnormal_dopamine_level | 1.58995423 |
34 | MP0009840_abnormal_foam_cell | 1.58360285 |
35 | MP0003448_altered_tumor_morphology | 1.58179251 |
36 | MP0000462_abnormal_digestive_system | 1.56385175 |
37 | MP0005023_abnormal_wound_healing | 1.52244075 |
38 | MP0005275_abnormal_skin_tensile | 1.50561268 |
39 | MP0001661_extended_life_span | 1.48920782 |
40 | MP0004885_abnormal_endolymph | 1.48810566 |
41 | MP0001853_heart_inflammation | 1.46693195 |
42 | MP0004742_abnormal_vestibular_system | 1.45834189 |
43 | MP0000015_abnormal_ear_pigmentation | 1.44129402 |
44 | MP0003172_abnormal_lysosome_physiology | 1.43206936 |
45 | MP0003632_abnormal_nervous_system | 1.41452656 |
46 | MP0006082_CNS_inflammation | 1.41029166 |
47 | MP0002166_altered_tumor_susceptibility | 1.40432271 |
48 | MP0010771_integument_phenotype | 1.39916559 |
49 | MP0010352_gastrointestinal_tract_polyps | 1.39639700 |
50 | MP0004233_abnormal_muscle_weight | 1.35501653 |
51 | MP0008260_abnormal_autophagy | 1.35159974 |
52 | MP0000003_abnormal_adipose_tissue | 1.35148919 |
53 | MP0005623_abnormal_meninges_morphology | 1.34548667 |
54 | MP0002933_joint_inflammation | 1.32643877 |
55 | MP0003186_abnormal_redox_activity | 1.32352471 |
56 | MP0002006_tumorigenesis | 1.31313099 |
57 | MP0001879_abnormal_lymphatic_vessel | 1.28831403 |
58 | MP0009384_cardiac_valve_regurgitation | 1.28446818 |
59 | MP0005165_increased_susceptibility_to | 1.27751170 |
60 | MP0001958_emphysema | 1.26905141 |
61 | MP0001529_abnormal_vocalization | 1.26173326 |
62 | MP0000858_altered_metastatic_potential | 1.25772520 |
63 | MP0001851_eye_inflammation | 1.25064609 |
64 | MP0002229_neurodegeneration | 1.23119086 |
65 | MP0010678_abnormal_skin_adnexa | 1.23040580 |
66 | MP0009780_abnormal_chondrocyte_physiolo | 1.19800377 |
67 | MP0003828_pulmonary_edema | 1.18313573 |
68 | MP0010386_abnormal_urinary_bladder | 1.18207039 |
69 | MP0005197_abnormal_uvea_morphology | 1.17247035 |
70 | MP0005503_abnormal_tendon_morphology | 1.15916651 |
71 | MP0001542_abnormal_bone_strength | 1.14999299 |
72 | MP0000767_abnormal_smooth_muscle | 1.14629195 |
73 | MP0001485_abnormal_pinna_reflex | 1.13180100 |
74 | MP0009053_abnormal_anal_canal | 1.12768119 |
75 | MP0003279_aneurysm | 1.11298380 |
76 | MP0003724_increased_susceptibility_to | 1.11198624 |
77 | MP0002148_abnormal_hypersensitivity_rea | 1.09132820 |
78 | MP0004185_abnormal_adipocyte_glucose | 1.08264246 |
79 | MP0002102_abnormal_ear_morphology | 1.08023923 |
80 | MP0008007_abnormal_cellular_replicative | 1.07891616 |
81 | MP0001191_abnormal_skin_condition | 1.07316527 |
82 | MP0000383_abnormal_hair_follicle | 1.05542896 |
83 | MP0000343_altered_response_to | 1.04730094 |
84 | MP0004142_abnormal_muscle_tone | 1.03587662 |
85 | MP0000747_muscle_weakness | 1.01485674 |
86 | MP0000749_muscle_degeneration | 0.98652513 |
87 | MP0003183_abnormal_peptide_metabolism | 0.98082749 |
88 | MP0001348_abnormal_lacrimal_gland | 0.96870916 |
89 | MP0000647_abnormal_sebaceous_gland | 0.94984980 |
90 | MP0003283_abnormal_digestive_organ | 0.94124037 |
91 | MP0003786_premature_aging | 0.93980482 |
92 | MP0005164_abnormal_response_to | 0.93272310 |
93 | MP0005257_abnormal_intraocular_pressure | 0.93162646 |
94 | MP0000358_abnormal_cell_content/ | 0.92433931 |
95 | MP0004957_abnormal_blastocyst_morpholog | 0.92158151 |
96 | MP0002272_abnormal_nervous_system | 0.91432108 |
97 | MP0004134_abnormal_chest_morphology | 0.91341580 |
98 | MP0001346_abnormal_lacrimal_gland | 0.89218535 |
99 | MP0001243_abnormal_dermal_layer | 0.87685898 |
100 | MP0005083_abnormal_biliary_tract | 0.87516661 |
101 | MP0000377_abnormal_hair_follicle | 0.87178519 |
102 | MP0002734_abnormal_mechanical_nocicepti | 0.86565585 |
103 | MP0003631_nervous_system_phenotype | 0.86406126 |
104 | MP0002177_abnormal_outer_ear | 0.86088984 |
105 | MP0004147_increased_porphyrin_level | 0.85626568 |
106 | MP0005508_abnormal_skeleton_morphology | 0.85025277 |
107 | MP0009931_abnormal_skin_appearance | 0.84542888 |
108 | MP0004858_abnormal_nervous_system | 0.84335222 |
109 | MP0004782_abnormal_surfactant_physiolog | 0.84140736 |
110 | MP0005390_skeleton_phenotype | 0.83876575 |
111 | MP0005193_abnormal_anterior_eye | 0.82837049 |
112 | MP0002095_abnormal_skin_pigmentation | 0.81338165 |
113 | MP0001533_abnormal_skeleton_physiology | 0.81330828 |
114 | MP0002837_dystrophic_cardiac_calcinosis | 0.79741269 |
115 | MP0000762_abnormal_tongue_morphology | 0.79684427 |
116 | MP0002254_reproductive_system_inflammat | 0.79498058 |
117 | MP0005174_abnormal_tail_pigmentation | 0.78724387 |
118 | MP0001881_abnormal_mammary_gland | 0.78554208 |
119 | MP0009643_abnormal_urine_homeostasis | 0.78536638 |
120 | MP0005647_abnormal_sex_gland | 0.78390093 |
121 | MP0000627_abnormal_mammary_gland | 0.78182065 |
122 | MP0000579_abnormal_nail_morphology | 0.78066970 |
123 | MP0010030_abnormal_orbit_morphology | 0.77991315 |
124 | MP0003453_abnormal_keratinocyte_physiol | 0.77811985 |
125 | MP0003011_delayed_dark_adaptation | 0.77648408 |
126 | MP0009333_abnormal_splenocyte_physiolog | 0.77097376 |
127 | MP0008932_abnormal_embryonic_tissue | 0.75405298 |
128 | MP0005379_endocrine/exocrine_gland_phen | 0.75187306 |
129 | MP0005595_abnormal_vascular_smooth | 0.73940654 |
130 | MP0001986_abnormal_taste_sensitivity | 0.73783980 |
131 | MP0003633_abnormal_nervous_system | 0.73566583 |
132 | MP0000372_irregular_coat_pigmentation | 0.72976625 |
133 | MP0002118_abnormal_lipid_homeostasis | 0.72837525 |
134 | MP0005388_respiratory_system_phenotype | 0.72143200 |
135 | MP0002133_abnormal_respiratory_system | 0.72143200 |
136 | MP0010368_abnormal_lymphatic_system | 0.70652177 |
137 | MP0003937_abnormal_limbs/digits/tail_de | 0.70452418 |
138 | MP0005332_abnormal_amino_acid | 0.70409895 |
139 | MP0002090_abnormal_vision | 0.70246694 |
140 | MP0002009_preneoplasia | 0.70127931 |
141 | MP0001727_abnormal_embryo_implantation | 0.69861204 |
142 | MP0001970_abnormal_pain_threshold | 0.69708969 |
143 | MP0000230_abnormal_systemic_arterial | 0.69179134 |
144 | MP0002998_abnormal_bone_remodeling | 0.68416615 |
145 | MP0000613_abnormal_salivary_gland | 0.68042472 |
146 | MP0002098_abnormal_vibrissa_morphology | 0.67657852 |
147 | MP0000639_abnormal_adrenal_gland | 0.66905376 |
148 | MP0004036_abnormal_muscle_relaxation | 0.66603233 |
149 | MP0003075_altered_response_to | 0.65421259 |
150 | MP0000467_abnormal_esophagus_morphology | 0.64952754 |
151 | MP0009250_abnormal_appendicular_skeleto | 0.64778547 |
152 | MP0009785_altered_susceptibility_to | 0.64319922 |
153 | MP0008058_abnormal_DNA_repair | 0.64101596 |
154 | MP0003315_abnormal_perineum_morphology | 0.63890507 |
155 | MP0002896_abnormal_bone_mineralization | 0.63852419 |
156 | MP0005410_abnormal_fertilization | 0.63816241 |
157 | MP0003795_abnormal_bone_structure | 0.63338858 |
158 | MP0003091_abnormal_cell_migration | 0.63081507 |
159 | MP0005375_adipose_tissue_phenotype | 0.62708672 |
160 | MP0000955_abnormal_spinal_cord | 0.62519077 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Neurofibrillary tangles (HP:0002185) | 5.91956943 |
2 | Follicular hyperkeratosis (HP:0007502) | 5.03753568 |
3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.00522958 |
4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.00522958 |
5 | Parakeratosis (HP:0001036) | 4.12608697 |
6 | Cerebral inclusion bodies (HP:0100314) | 4.10275541 |
7 | Protrusio acetabuli (HP:0003179) | 3.94582310 |
8 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.92446413 |
9 | Premature rupture of membranes (HP:0001788) | 3.62240584 |
10 | Ankle contracture (HP:0006466) | 3.60374617 |
11 | Sensory axonal neuropathy (HP:0003390) | 3.59169329 |
12 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.51217352 |
13 | Vertebral compression fractures (HP:0002953) | 3.51041359 |
14 | Onycholysis (HP:0001806) | 3.48958402 |
15 | Alopecia of scalp (HP:0002293) | 3.36593804 |
16 | Abnormality of the corticospinal tract (HP:0002492) | 3.34944410 |
17 | Autoamputation (HP:0001218) | 3.23322601 |
18 | Onion bulb formation (HP:0003383) | 3.14750620 |
19 | Sparse eyelashes (HP:0000653) | 3.06958169 |
20 | Hypotrichosis (HP:0001006) | 2.99625345 |
21 | Vacuolated lymphocytes (HP:0001922) | 2.96292175 |
22 | Palmoplantar hyperkeratosis (HP:0000972) | 2.96149573 |
23 | Supranuclear gaze palsy (HP:0000605) | 2.94994813 |
24 | Dysostosis multiplex (HP:0000943) | 2.92061206 |
25 | Atrophic scars (HP:0001075) | 2.91924851 |
26 | Peripheral hypomyelination (HP:0007182) | 2.91109302 |
27 | Abnormality of the axillary hair (HP:0100134) | 2.91100061 |
28 | Abnormality of secondary sexual hair (HP:0009888) | 2.91100061 |
29 | Hypokinesia (HP:0002375) | 2.90842267 |
30 | Aortic dissection (HP:0002647) | 2.89822239 |
31 | Termporal pattern (HP:0011008) | 2.86184230 |
32 | Insidious onset (HP:0003587) | 2.86184230 |
33 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.85270344 |
34 | Erythema (HP:0010783) | 2.83232724 |
35 | Axonal loss (HP:0003447) | 2.81694583 |
36 | Palmar hyperkeratosis (HP:0010765) | 2.80861618 |
37 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.80778102 |
38 | Soft skin (HP:0000977) | 2.72243631 |
39 | Plantar hyperkeratosis (HP:0007556) | 2.71459128 |
40 | Erythroderma (HP:0001019) | 2.70566976 |
41 | Entropion (HP:0000621) | 2.68795573 |
42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.68701983 |
43 | Conjunctival hamartoma (HP:0100780) | 2.61770173 |
44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.59460672 |
45 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.59460096 |
46 | Aplastic anemia (HP:0001915) | 2.58748916 |
47 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.58393649 |
48 | Retinal dysplasia (HP:0007973) | 2.58083445 |
49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57939044 |
50 | Cerebral hemorrhage (HP:0001342) | 2.53252406 |
51 | Cerebral hypomyelination (HP:0006808) | 2.52530007 |
52 | Type I transferrin isoform profile (HP:0003642) | 2.51829269 |
53 | Increased cerebral lipofuscin (HP:0011813) | 2.51797956 |
54 | Progressive neurologic deterioration (HP:0002344) | 2.49270663 |
55 | Elbow flexion contracture (HP:0002987) | 2.48592981 |
56 | Nonimmune hydrops fetalis (HP:0001790) | 2.48559344 |
57 | Abnormality of nail color (HP:0100643) | 2.47093598 |
58 | Degeneration of anterior horn cells (HP:0002398) | 2.46898343 |
59 | Abnormality of the anterior horn cell (HP:0006802) | 2.46898343 |
60 | Increased circulating renin level (HP:0000848) | 2.46852873 |
61 | Bladder diverticulum (HP:0000015) | 2.45886031 |
62 | Premature skin wrinkling (HP:0100678) | 2.43290483 |
63 | Hypomagnesemia (HP:0002917) | 2.43208315 |
64 | Cervical subluxation (HP:0003308) | 2.41352847 |
65 | Stridor (HP:0010307) | 2.39886998 |
66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.39686871 |
67 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.39686871 |
68 | Abnormal protein glycosylation (HP:0012346) | 2.39686871 |
69 | Abnormal glycosylation (HP:0012345) | 2.39686871 |
70 | Pheochromocytoma (HP:0002666) | 2.37455309 |
71 | Hepatosplenomegaly (HP:0001433) | 2.35226026 |
72 | Nail dystrophy (HP:0008404) | 2.35152307 |
73 | Hypokalemic alkalosis (HP:0001949) | 2.35077502 |
74 | Abnormal auditory evoked potentials (HP:0006958) | 2.30524125 |
75 | Osteolytic defects of the hand bones (HP:0009699) | 2.28956491 |
76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28956491 |
77 | Abnormality of glycolysis (HP:0004366) | 2.28492576 |
78 | Increased serum pyruvate (HP:0003542) | 2.28492576 |
79 | Redundant skin (HP:0001582) | 2.28364358 |
80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28332995 |
81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28332995 |
82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28332995 |
83 | Coronal craniosynostosis (HP:0004440) | 2.27999748 |
84 | Abnormality of the umbilical cord (HP:0010881) | 2.27380886 |
85 | Upper motor neuron abnormality (HP:0002127) | 2.27366205 |
86 | Aplasia of the phalanges of the hand (HP:0009802) | 2.27217630 |
87 | Aplasia involving bones of the extremities (HP:0009825) | 2.27217630 |
88 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.27217630 |
89 | Fragile skin (HP:0001030) | 2.25250971 |
90 | Hypoglycemic seizures (HP:0002173) | 2.25123908 |
91 | Tetraparesis (HP:0002273) | 2.23964655 |
92 | Blue sclerae (HP:0000592) | 2.23700089 |
93 | Microretrognathia (HP:0000308) | 2.21717490 |
94 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.19089032 |
95 | Single umbilical artery (HP:0001195) | 2.19089032 |
96 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.19089032 |
97 | Generalized amyotrophy (HP:0003700) | 2.18595200 |
98 | Spinal rigidity (HP:0003306) | 2.17292469 |
99 | Thickened helices (HP:0000391) | 2.15828649 |
100 | Spastic gait (HP:0002064) | 2.15672622 |
101 | Thick nail (HP:0001805) | 2.15296895 |
102 | Alacrima (HP:0000522) | 2.14510639 |
103 | Ectropion (HP:0000656) | 2.13756264 |
104 | Episodic fever (HP:0001954) | 2.12987169 |
105 | Natal tooth (HP:0000695) | 2.12857887 |
106 | Spastic paraparesis (HP:0002313) | 2.12613273 |
107 | Fragile nails (HP:0001808) | 2.11783973 |
108 | Loss of speech (HP:0002371) | 2.10727968 |
109 | Symptomatic seizures (HP:0011145) | 2.10374007 |
110 | Neuroendocrine neoplasm (HP:0100634) | 2.10225145 |
111 | Genu recurvatum (HP:0002816) | 2.08724219 |
112 | Selective tooth agenesis (HP:0001592) | 2.08077960 |
113 | Akinesia (HP:0002304) | 2.05266184 |
114 | Esophageal neoplasm (HP:0100751) | 2.05203486 |
115 | Neoplasm of head and neck (HP:0012288) | 2.05203486 |
116 | Intention tremor (HP:0002080) | 2.04752217 |
117 | Anteriorly placed anus (HP:0001545) | 2.04731450 |
118 | Abnormality of magnesium homeostasis (HP:0004921) | 2.04583705 |
119 | Abnormality of dentin (HP:0010299) | 2.03718686 |
120 | Clumsiness (HP:0002312) | 2.03478852 |
121 | Trismus (HP:0000211) | 2.03104570 |
122 | Mucopolysacchariduria (HP:0008155) | 2.02432804 |
123 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02432804 |
124 | Short clavicles (HP:0000894) | 2.01526345 |
125 | Reduced antithrombin III activity (HP:0001976) | 1.99280888 |
126 | Poor head control (HP:0002421) | 1.96898842 |
127 | Muscle fiber splitting (HP:0003555) | 1.95829038 |
128 | Split foot (HP:0001839) | 1.94867092 |
129 | Increased IgE level (HP:0003212) | 1.94557535 |
130 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94250387 |
131 | Abnormality of alanine metabolism (HP:0010916) | 1.94250387 |
132 | Hyperalaninemia (HP:0003348) | 1.94250387 |
133 | Woolly hair (HP:0002224) | 1.94233120 |
134 | Slow saccadic eye movements (HP:0000514) | 1.94053279 |
135 | Peripheral demyelination (HP:0011096) | 1.93725471 |
136 | Patchy hypopigmentation of hair (HP:0011365) | 1.91883816 |
137 | Anhidrosis (HP:0000970) | 1.91347689 |
138 | Protuberant abdomen (HP:0001538) | 1.91140835 |
139 | Prolonged neonatal jaundice (HP:0006579) | 1.90520690 |
140 | Oral leukoplakia (HP:0002745) | 1.90512507 |
141 | Mitral stenosis (HP:0001718) | 1.90109334 |
142 | Cardiovascular calcification (HP:0011915) | 1.89625629 |
143 | Infantile muscular hypotonia (HP:0008947) | 1.89322343 |
144 | Foot dorsiflexor weakness (HP:0009027) | 1.88772422 |
145 | Disproportionate short-trunk short stature (HP:0003521) | 1.87359352 |
146 | Corneal erosion (HP:0200020) | 1.85945674 |
147 | Spondylolisthesis (HP:0003302) | 1.85823641 |
148 | Amyloidosis (HP:0011034) | 1.83897737 |
149 | Aortic aneurysm (HP:0004942) | 1.82636703 |
150 | Arterial tortuosity (HP:0005116) | 1.82536475 |
151 | Leukodystrophy (HP:0002415) | 1.81557322 |
152 | Barrel-shaped chest (HP:0001552) | 1.81545525 |
153 | Hypoglycemic coma (HP:0001325) | 1.80987817 |
154 | Hyporeflexia of lower limbs (HP:0002600) | 1.80945805 |
155 | Hypophosphatemic rickets (HP:0004912) | 1.80856933 |
156 | Vascular tortuosity (HP:0004948) | 1.80838045 |
157 | Gowers sign (HP:0003391) | 1.79846073 |
158 | Humeroradial synostosis (HP:0003041) | 1.79518162 |
159 | Synostosis involving the elbow (HP:0003938) | 1.79518162 |
160 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79045112 |
161 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79045112 |
162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79045112 |
163 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.78596249 |
164 | Short middle phalanx of the 5th finger (HP:0004220) | 1.78468470 |
165 | Abnormality of macrophages (HP:0004311) | 1.77893726 |
166 | Dysmetria (HP:0001310) | 1.77837213 |
167 | Dilatation of the ascending aorta (HP:0005111) | 1.77795660 |
168 | Hypoplasia of the odontoid process (HP:0003311) | 1.77664256 |
169 | Wormian bones (HP:0002645) | 1.77086938 |
170 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.77067998 |
171 | Adrenal hypoplasia (HP:0000835) | 1.76017138 |
172 | Metabolic alkalosis (HP:0200114) | 1.73853623 |
173 | Peritonitis (HP:0002586) | 1.72766802 |
174 | Hypoplasia of the iris (HP:0007676) | 1.72753733 |
175 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.71585098 |
176 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.71441628 |
177 | Methylmalonic acidemia (HP:0002912) | 1.70412857 |
178 | Intrahepatic cholestasis (HP:0001406) | 1.65158164 |
179 | Large for gestational age (HP:0001520) | 1.64457207 |
180 | Fused cervical vertebrae (HP:0002949) | 1.64203950 |
181 | Type II lissencephaly (HP:0007260) | 1.64142685 |
182 | Hypoplastic pelvis (HP:0008839) | 1.62363916 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 5.65650125 |
2 | OXSR1 | 4.02308059 |
3 | PDK2 | 3.68144013 |
4 | EPHB1 | 3.55752660 |
5 | MET | 3.12345923 |
6 | WNK4 | 2.96054422 |
7 | PBK | 2.95546123 |
8 | LIMK1 | 2.94017648 |
9 | BCR | 2.90722295 |
10 | MYLK | 2.65263669 |
11 | NTRK1 | 2.49665761 |
12 | BUB1 | 2.43840867 |
13 | TESK2 | 2.37398525 |
14 | NME2 | 2.30552921 |
15 | NEK1 | 2.28786617 |
16 | WEE1 | 2.26020952 |
17 | BRSK2 | 2.22513485 |
18 | MAP3K12 | 2.15613892 |
19 | MAP3K3 | 2.11211179 |
20 | WNK1 | 1.99976201 |
21 | TGFBR2 | 1.98099099 |
22 | PAK4 | 1.95392054 |
23 | PIM2 | 1.90459778 |
24 | MAPKAPK5 | 1.90185046 |
25 | NEK9 | 1.88899800 |
26 | INSRR | 1.87039619 |
27 | IRAK3 | 1.83515155 |
28 | TRIM28 | 1.82816368 |
29 | SIK3 | 1.81813735 |
30 | ERBB3 | 1.76200968 |
31 | ARAF | 1.75535164 |
32 | FGFR2 | 1.74958799 |
33 | PKN1 | 1.68479550 |
34 | MST4 | 1.59690510 |
35 | EPHA2 | 1.56856847 |
36 | MOS | 1.56015325 |
37 | MAPK15 | 1.48821201 |
38 | NEK6 | 1.48501010 |
39 | CSNK1G3 | 1.46110752 |
40 | TAOK2 | 1.45163040 |
41 | CSNK1A1L | 1.43867415 |
42 | EIF2AK1 | 1.42654637 |
43 | ERBB4 | 1.40651181 |
44 | BRSK1 | 1.37357044 |
45 | ROCK2 | 1.35202700 |
46 | GRK1 | 1.32289949 |
47 | PAK3 | 1.31817375 |
48 | GRK7 | 1.26474839 |
49 | MAP3K14 | 1.25176519 |
50 | TRPM7 | 1.22403563 |
51 | TSSK6 | 1.21242182 |
52 | SCYL2 | 1.21146906 |
53 | CAMK2B | 1.20817066 |
54 | CAMK2D | 1.18691196 |
55 | SRPK1 | 1.18572248 |
56 | BCKDK | 1.17544774 |
57 | CSNK1G1 | 1.12632170 |
58 | MAP3K2 | 1.09470893 |
59 | PRPF4B | 1.06137967 |
60 | FGR | 1.04665545 |
61 | PTK2 | 1.03818474 |
62 | NUAK1 | 1.03658941 |
63 | CDK19 | 1.03132704 |
64 | ILK | 1.01747358 |
65 | MAPKAPK3 | 0.99153379 |
66 | KSR2 | 0.99145158 |
67 | CSNK1G2 | 0.97156397 |
68 | CAMK2G | 0.92965055 |
69 | RAF1 | 0.87860986 |
70 | UHMK1 | 0.87595641 |
71 | PAK6 | 0.86862236 |
72 | EIF2AK3 | 0.86586114 |
73 | IRAK1 | 0.85563168 |
74 | BMPR1B | 0.83303871 |
75 | PRKCE | 0.80589492 |
76 | ABL2 | 0.79622834 |
77 | CDK14 | 0.79544128 |
78 | MAP2K2 | 0.79223008 |
79 | LATS1 | 0.79018933 |
80 | BMPR2 | 0.78584295 |
81 | PRKD1 | 0.78252786 |
82 | TESK1 | 0.77474110 |
83 | TAOK3 | 0.77019224 |
84 | MST1R | 0.74537543 |
85 | SGK494 | 0.74362412 |
86 | SGK223 | 0.74362412 |
87 | PLK2 | 0.73829500 |
88 | CDK8 | 0.73243355 |
89 | PDGFRA | 0.72696524 |
90 | CLK1 | 0.72458752 |
91 | DYRK2 | 0.71462027 |
92 | HIPK2 | 0.71038170 |
93 | TXK | 0.70736423 |
94 | EIF2AK2 | 0.69385942 |
95 | IKBKB | 0.68392837 |
96 | STK10 | 0.68029200 |
97 | DDR2 | 0.67806983 |
98 | ERN1 | 0.66372777 |
99 | TBK1 | 0.66052286 |
100 | VRK2 | 0.65479187 |
101 | PRKD2 | 0.64515560 |
102 | PRKCQ | 0.62977637 |
103 | GSK3A | 0.62955001 |
104 | IRAK4 | 0.62909614 |
105 | PRKCH | 0.61971588 |
106 | PRKD3 | 0.60088694 |
107 | BRAF | 0.60080015 |
108 | FLT3 | 0.59576809 |
109 | MAP3K13 | 0.59526506 |
110 | EPHA3 | 0.59497670 |
111 | CAMK2A | 0.59474148 |
112 | TGFBR1 | 0.58814190 |
113 | MAP3K8 | 0.58554219 |
114 | CSK | 0.58537634 |
115 | ITK | 0.58053289 |
116 | IRAK2 | 0.55537429 |
117 | CDK7 | 0.53948833 |
118 | CDK15 | 0.51106118 |
119 | PDPK1 | 0.50926320 |
120 | DAPK3 | 0.50894670 |
121 | CDK6 | 0.50510243 |
122 | PDGFRB | 0.49156741 |
123 | MAP3K1 | 0.49055914 |
124 | STK38 | 0.48544640 |
125 | FER | 0.48319653 |
126 | AKT3 | 0.47560537 |
127 | TIE1 | 0.47523473 |
128 | CDK18 | 0.47450897 |
129 | DAPK1 | 0.46805952 |
130 | PAK1 | 0.46720335 |
131 | INSR | 0.46427600 |
132 | PLK3 | 0.46257983 |
133 | TYK2 | 0.45758542 |
134 | PTK2B | 0.45647522 |
135 | TYRO3 | 0.45547949 |
136 | STK16 | 0.45427241 |
137 | RPS6KA5 | 0.43128426 |
138 | PAK2 | 0.42394423 |
139 | LATS2 | 0.42350127 |
140 | CDK11A | 0.42033740 |
141 | FYN | 0.41522033 |
142 | KDR | 0.40808279 |
143 | LRRK2 | 0.38381787 |
144 | BMX | 0.37938187 |
145 | PIK3CA | 0.37758309 |
146 | CSNK1A1 | 0.37647699 |
147 | ADRBK1 | 0.37288884 |
148 | PIK3CG | 0.35953239 |
149 | PLK1 | 0.35497982 |
150 | CDK5 | 0.35045592 |
151 | PRKG1 | 0.34426670 |
152 | ROCK1 | 0.34193782 |
153 | CAMKK2 | 0.32179477 |
154 | MAP2K1 | 0.31600765 |
155 | AURKB | 0.31450614 |
156 | ABL1 | 0.31363979 |
157 | MARK3 | 0.28689255 |
158 | MAPKAPK2 | 0.27971476 |
159 | RET | 0.27758561 |
160 | BLK | 0.27191458 |
161 | IGF1R | 0.27127780 |
162 | JAK1 | 0.26949879 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.73304362 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.56575509 |
3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.52501254 |
4 | Protein export_Homo sapiens_hsa03060 | 4.29715750 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.86194215 |
6 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.00429089 |
7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.74401675 |
8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.62956443 |
9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.58946820 |
10 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.53793829 |
11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.39322191 |
12 | Lysosome_Homo sapiens_hsa04142 | 2.24110118 |
13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12108722 |
14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.07545980 |
15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91053960 |
16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.87779376 |
17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82918777 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79824927 |
19 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.77566312 |
20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.75427023 |
21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.62868112 |
22 | DNA replication_Homo sapiens_hsa03030 | 1.45097364 |
23 | Phagosome_Homo sapiens_hsa04145 | 1.44793593 |
24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44128150 |
25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.43959726 |
26 | RNA polymerase_Homo sapiens_hsa03020 | 1.40487868 |
27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.38526694 |
28 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.34376673 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33640238 |
30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.33196942 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31942973 |
32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.31141027 |
33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29709415 |
34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27791866 |
35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.27598339 |
36 | Legionellosis_Homo sapiens_hsa05134 | 1.26431992 |
37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.26220965 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23769446 |
39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.22562776 |
40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18295413 |
41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17799954 |
42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16898571 |
43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16829758 |
44 | Malaria_Homo sapiens_hsa05144 | 1.16573523 |
45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16000359 |
46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12953711 |
47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11410737 |
48 | Base excision repair_Homo sapiens_hsa03410 | 1.10468429 |
49 | Bladder cancer_Homo sapiens_hsa05219 | 1.04190946 |
50 | Mismatch repair_Homo sapiens_hsa03430 | 1.03086428 |
51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00258255 |
52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99733690 |
53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97092304 |
54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95987465 |
55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95524836 |
56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94913724 |
57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94894846 |
58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90856386 |
59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90487749 |
60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89308083 |
61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89134470 |
62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88887062 |
63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86397432 |
64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86219839 |
65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85213147 |
66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84900685 |
67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84257073 |
68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84157785 |
69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83351510 |
70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82617944 |
71 | Peroxisome_Homo sapiens_hsa04146 | 0.81894039 |
72 | Axon guidance_Homo sapiens_hsa04360 | 0.80623149 |
73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80487218 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.79720203 |
75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79408421 |
76 | Mineral absorption_Homo sapiens_hsa04978 | 0.78342436 |
77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75123201 |
78 | RNA transport_Homo sapiens_hsa03013 | 0.75002250 |
79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73596062 |
80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72925818 |
81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72186949 |
82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72151006 |
83 | Tight junction_Homo sapiens_hsa04530 | 0.70895366 |
84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69516556 |
85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68748614 |
86 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62920556 |
87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62692325 |
88 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62498996 |
89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62437484 |
90 | Prion diseases_Homo sapiens_hsa05020 | 0.61191150 |
91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60908484 |
92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60824330 |
93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60787917 |
94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59536819 |
95 | Spliceosome_Homo sapiens_hsa03040 | 0.59256866 |
96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56911010 |
97 | Cell cycle_Homo sapiens_hsa04110 | 0.56210016 |
98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53739048 |
99 | Apoptosis_Homo sapiens_hsa04210 | 0.53289893 |
100 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52920564 |
101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52549766 |
102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52123639 |
103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52052786 |
104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51992086 |
105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51402088 |
106 | RNA degradation_Homo sapiens_hsa03018 | 0.51388862 |
107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50864724 |
108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.49596277 |
109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49250446 |
110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48923123 |
111 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48639161 |
112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.48233871 |
113 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48218874 |
114 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.48036767 |
115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47800652 |
116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47617864 |
117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47571096 |
118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47408320 |
119 | Shigellosis_Homo sapiens_hsa05131 | 0.47327595 |
120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46475578 |
121 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46096381 |
122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44310804 |
123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42802862 |
124 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42755083 |
125 | Focal adhesion_Homo sapiens_hsa04510 | 0.42745967 |
126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41956706 |
127 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41814320 |
128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41675561 |
129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41536395 |
130 | Purine metabolism_Homo sapiens_hsa00230 | 0.40921087 |
131 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40860572 |
132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39600567 |
133 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39017806 |
134 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38920772 |
135 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38859754 |
136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38023586 |
137 | Amoebiasis_Homo sapiens_hsa05146 | 0.37373095 |
138 | Pertussis_Homo sapiens_hsa05133 | 0.37149317 |
139 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36403434 |
140 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.35881636 |
141 | Salmonella infection_Homo sapiens_hsa05132 | 0.31753426 |
142 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30881775 |
143 | Asthma_Homo sapiens_hsa05310 | 0.27723780 |
144 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.27144816 |
145 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27036957 |
146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26718234 |
147 | Prostate cancer_Homo sapiens_hsa05215 | 0.23705311 |
148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.21304391 |
149 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20913731 |
150 | Long-term depression_Homo sapiens_hsa04730 | 0.20688035 |
151 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.20170070 |
152 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19348328 |
153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18741532 |